FOLD - Amicus Therapeutics EPS misses by $0.04 beats on revenue November, 05 2020 07:08 AM Amicus Therapeutics Inc. Amicus Therapeutics (FOLD): Q3 GAAP EPS of -$0.25 misses by $0.04.Revenue of $67.44M (+38.3% Y/Y) beats by $2.56M.Shares -0.73% PM.Press Release For further details see: Amicus Therapeutics EPS misses by $0.04, beats on revenue